Jinshiya Medicine: It is expected that the net profit in the first half of the year will increase by 50.04%-85.24% year-on-year.

Goldstone Asia Medicine announced that the expected net profit for the first half of 2025 is between 58.8172 million and 72.6178 million, a growth of 50.04% to 85.24% compared to the same period last year.